Log In
BCIQ
Print this Print this
 

Beta amyloid

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Beta amyloid

BCIQ
Print ChartPrint this
2 - Diagnostic 1 - Diagnostic 5 - Neurology 1 - Diagnostic 1 - Ophthalmic 7 - Neurology 1 - Diagnostic 1 - Neurology 1 - Ophthalmic 11 - Neurology 2 - Diagnostic 1 - Ophthalmic 9 - Neurology 1 - Diagnostic 2 - Neurology 1 - Endocrine / Metabolic
Phase of DevelopmentDiscoveryPreclinicalPilotPhase IPhase I/IIPhase IIPhase IIIApprovedMarketed
Diagnostic

-

1

2

-

-

1

1

1

2

Endocrine / Metabolic

1

-

-

-

-

-

-

-

-

Neurology

2

9

-

11

1

7

5

-

-

Ophthalmic

-

1

-

1

-

1

-

-

-




 Products Targeting Beta amyloid
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

25

$11,769.5M

$3,814.8M

$677.5M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today